Product label: Back Order

Product label: Back Order

Image

Product Name

Wholesaler

Strength/Pack Size

Product Info

Olmesartan

More info

Indication:

Olmesartan medoxomil is indicated for the treatment of hypertension.

Generic Name: Olmesartan

Strength:20mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off white coloured, round shape film coated tablets debossed with OLM on one side & 20 on other side

Segment :B

Innovator:Olmetec®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: olmesartan medoxomil 20mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2016-PI-01332-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2016-CMI-01331-1

Omeprazole

More info

Indication:

The relief of heartburn and other symptoms associated with GORD. The treatment and prevention of relapse in erosive oesophagitis. The treatment of duodenal and gastric ulcer. Combination therapy for the treatment of peptic ulcer disease associated with H. pylori infection. The treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs.The prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer. Long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be H. pylori negative, or in whom eradication is inappropriate, e.g. the elderly or ineffective. The treatment of Zollinger-Ellison syndrome.

Generic Name: Omeprazole

Strength:20mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:Opaque yellow cap and body No 2 hard gelatin capsules containing off-white )ivory) to cream-white spherical microgranules

Segment :B

Innovator:Probitor®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: omeprazole 20mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-03236-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-03271-1

Pharmacor Mycophenolate Oral Suspension x 1 (1 unit – 165mL)

More info

Indication:

Pharmacor Mycophenolate is indicated for the prophylaxis of solid organ rejection in adults receiving
allogeneic organ transplants.,Pharmacor Mycophenolate is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Generic Name: Mycophenolate mofetil

Strength:1g/5ml

Dosage:

Shelflife Months: 24

Pack Size: 1

Tablet Description:

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: mycophenolate mofetil 200mg/ml

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02212-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02209-1

Plavicor 75mg x 28 tabs

More info

Indication:

For prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. ,Acute Coronary Syndrome: Clopidogrel Tablets is indicated in combination with aspirin for patients with: ,- Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel Tablets is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularization (surgical or PCI, with or without stent); ,- ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, Clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Generic Name: Clopidogrel

Strength:75mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 28

Tablet Description:Pink coloured, round, biconvex, film coated tablets, debossed with 'Cl' on one side and plain on other side

Segment :B

Innovator:Plavix®

PBSListed:Yes

RPBSlisted:Yes

Schedule:S4

Storage Conditions:
Store below 25 degrees Celsius

Active Ingredients: clopidogrel hydrogen sulfate 97.875mg
Equivalent: clopidogrel 75mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01232-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01233-1

Posaconazole

More info

Indication:

Posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older:
Invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy.
Fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,Posaconazole is also indicated for the:
Prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (HSCT) recipients.

Generic Name: Posaconazole

Strength:100mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pharmacor Posaconazole modified release tablets is yellow, coated, capsule-shapred tablet containing 100 mg of posaconazole.

Segment :A

Innovator:Noxafil®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: posaconazole 100mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02636-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02639-1

Limited Stock

Quetiapine

More info

Indication:

Quetiapine is indicated for:,Bipolar disorder,Adults,ò Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes,ò Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration),ò Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate,Children/adolescents aged 10 to 17 years,ò Monotherapy treatment of acute mania associated with bipolar I disorder,Schizophrenia (adults and adolescents aged 13 to 17 years),ò Treatment of schizophrenia

Generic Name: Quetiapine

Strength:25mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 60

Tablet Description:Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side

Segment :B

Innovator:Seroquel®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-01381-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-01382-1

Rasagiline

More info

Indication:

PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Generic Name: Rasagiline

Strength:1mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side

Segment :A

Innovator:Azilect®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: rasagiline mesilate 1.56mg
Equivalent: rasagiline 1mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-02457-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-CMI-02459-1

Riluzole

More info

Indication:

Riluzole is indicated for the treatment of patients with amyotrophic lateral sclerosis (ALS)

Generic Name: Riluzole

Strength:50mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 56

Tablet Description:White to off-white coloured, capsule shaped film coated tablet, debossed with 'RIL' on one side and '50' on other side

Segment :A

Innovator:Rilutek ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: riluzole 50mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02319-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02325-1

Rosuvastatin calcium

More info

Indication:

PHARMACOR ROSUVASTATIN should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,Prevention of Cardiovascular Events
PHARMACOR ROSUVASTATIN is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking, or a family history of premature coronary heart disease). PHARMACOR ROSUVASTATIN is indicated to:,· Reduce the risk of nonfatal myocardial infarction
· Reduce the risk of nonfatal stroke
· Reduce the risk of coronary artery revascularisation procedures.,In patients with hypercholesterolaemia
PHARMACOR ROSUVASTATIN is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,Prior to initiating therapy with PHARMACOR ROSUVASTATIN, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Generic Name: Rosuvastatin calcium

Strength:5mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:Yellow, round, biconvex, film-coated tablet, debossed 5 on one side and R on other side

Segment :C

Innovator:Crestor®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: rosuvastatin calcium 5.21mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02337-2

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02338-2

Sitagliptin (as hydrochloride)

More info

Indication:

Sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type
2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- In combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 PHARMACODYNAMIC PROPERTIES, Clinical trials, 4.5 INTERACTIONS WITH OTHER
MEDICINES AND OTHER FORMS OF INTERACTIONS for available data on different add-on
combination therapies].

Generic Name: Sitagliptin (as hydrochloride)

Strength:25mg

Dosage:Tabs

Shelflife Months:

Pack Size: 28

Tablet Description:

Segment :A

Innovator: Januvia (Merck Sharp And Dohme Australia)

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: sitagliptin hydrochloride monohydrate 109mg
Equivalent: sitagliptin 100mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-01781-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-01793-1 https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-01781-1

Solifenacin

More info

Indication:

Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Generic Name: Solifenacin

Strength:5mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:Light yellow round shaped, film coated tablets debossed with S5 on one side and plain on other side.

Segment :A

Innovator:Vesicare®

PBSListed:No

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: solifenacin succinate 5mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-01581-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-CMI-01583-1

Sumatriptan

More info

Indication:

Generic Name: Sumatriptan

Strength:50mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 4

Tablet Description:

Segment :B

Innovator:Imigran ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:

Active Ingredients:

Tacrolimus

More info

Indication:

Tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Generic Name: Tacrolimus

Strength:0.5mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 100

Tablet Description:White to off white powder filled in size '5' yellow cap/body HGC printed with '0.5mg' on cap and 'Tacro' on body with red ink

Segment :A

Innovator:Prograf ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: tacrolimus monohydrate 0.51mg
Equivalent: tacrolimus 0.5mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-01875-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-01877-1 https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02507-1

Telmisartan

More info

Indication:

Telmisartan is indicated for:,Treatment of hypertension ,Prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

Generic Name: Telmisartan

Strength:40mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 28

Tablet Description:White to off white oblong shaped biconvex, uncoated tablets debossed with TEL on one side and 40 on other side

Segment :B

Innovator:Micardis ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: telmisartan 40mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-01879-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-01881-1

Teriflunomide

More info

Indication:

Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of Multiple Sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Generic Name: Teriflunomide

Strength:14mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 28

Tablet Description:Blue coloured, pentagonal shaped, film coated tablet, debossed with "T2" on one side and plain on other side.

Segment :A

Innovator:Aubagio®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: teriflunomide 14mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01280-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01308-1

Top Earner

Varenicline 1mg x 56 tabs bt

More info

Indication:

PHARMACOR VARENICLINE is indicated as an aid to smoking cessation in adults over the age of 18 years.

Generic Name: Varenicline

Strength:1mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 56

Tablet Description:Light blue, capsular biconvex, film coated tablets, debossed with VC on one side and 1 on other side.

Segment :A

Innovator:Myfortic ®

PBSListed:Yes

RPBSlisted:

Schedule:S5

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: varenicline tartrate 1.71mg
Equivalent: varenicline 1 mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-PI-02127-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-02125-1

Image

Product Name

Wholesaler

Strength/Pack Size

Product Info

Loratadine

More info

Indication:

For use in the treatment of both seasonal & perennial allergic rhinitis in adults & children 12 years of age or older. Also indicated for the relief of symptoms & signs of chronic urticaria in adults & children 12 years & older.

Generic Name: Loratadine

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 10

Tablet Description:White to off white uncoated tablets, breakline on one side and embossing on the other side

Segment :B

Innovator:Claratyne ®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: loratadine 10mg

Nystatin Oral Drops 24mL

More info

Indication:

Generic Name: Nystatin

Strength:24mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:Yellow coloured Homogenous Suspension

Segment :B

Innovator:Nilstat®

PBSListed:No

RPBSlisted:Yes

Schedule:S3

Storage Conditions:

Active Ingredients:

Zoptic Eye Drops (Ketotifen) 5mL

More info

Indication:

The symptomatic short term treatment of seasonal allergic conjunctivitis in adults and children 3 years or older.

Generic Name: Ketotifen

Strength:5mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:A clear, colorless solution

Segment :A

Innovator:Zaditen®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ketotifen fumarate 345 microgram/ml
Equivalent: ketotifen 250 microgram/ml

Gastrex

More info

Indication:

Symptomatic treatment of acute non-specific diarrhoea. Control and symptomatic treatment of chronic diarrhoea.

Generic Name: Gastrex

Strength:2mg

Dosage:Caps

Shelflife Months: 36

Pack Size: 12

Tablet Description:Hard gelatin capsule with grey cap and green body

Segment :A

Innovator:Imodium®

PBSListed:Yes

RPBSlisted:Yes

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: loperamide hydrochloride 2mg

Double Action Chesty Cough 200mL

More info

Indication:

Expectorant and mucolytic for the symptomatic relief of productive chesty coughs.

Generic Name: Double Action Chesty Cough

Strength:20mg/mL; 0.6mg/mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:Clear colourless liquid, free from particulate matter with strawberry and vanilla flavour

Segment :C

Innovator:Benadryl Chesty Forte®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: bromhexine hydrochloride 0.6mg/ml guaifenesin 20mg/ml

Osteo D

More info

Indication:

Aids/assists healthy bone development/growth/building
Maintain/support bone strength
Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life Maintain/support healthy muscle contraction function
Aid/assist muscle development

Generic Name: Osteo D

Strength:1000IU

Dosage:Caps

Shelflife Months: 24

Pack Size: 250

Tablet Description:Capsule, soft

Segment :B

Innovator:Ostelin®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:

Active Ingredients: colecalciferol 1000 IU

TFK Allervic Loratadine Liquid

More info

Indication:

For use in children 1-12 years of age, for relief of the symptoms of seasonal and non-seasonal allergic rhinitis such as sneezing, nasal discharge and itching, and itchy, watery eyes, and relief of symptoms of chronic urticaria (hives).

Generic Name: Loratadine

Strength:5mg/5mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:Clear, colourless solution with characteristic flavor filled in 170mL amber colored glass bottle with child resistant cap

Segment :B

Innovator:Claratyne Liquid®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: loratadine 1mg/ml

Image

Product Name

Wholesaler

Strength/Pack Size

Product Info

Gliclazide

More info

Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength:30mg

Dosage:MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description:White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator:Glyade MR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01570-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01869-1

Posaconazole

More info

Generic Name: Posaconazole

Strength:100mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pharmacor Posaconazole modified release tablets is yellow, coated, capsule-shapred tablet containing 100 mg of posaconazole.

Segment :A

Innovator:Noxafil®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: posaconazole 100mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02636-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02639-1

Filters

Sort by

SHOP POSTINOR-1

ENDS SOON

Sort by

No products found

Account Previous

Order history